Are you Dr. Edwards?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
771 West End Ave
New York, NY 10025Phone+1 216-255-5700Fax+1 216-255-5701
Summary
- Dr. Jon Edwards, MD is a board certified radiologist in New York, New York. He is currently licensed to practice medicine in New York, California, and Florida. He is affiliated with Maimonides Medical Center.
Education & Training
- University of California (San Francisco)Residency, Radiology-Diagnostic, 1973 - 1975
- Baylor College of MedicineResidency, Radiology-Diagnostic, 1972 - 1973
- Zuckerberg San Francisco General Hospital and Trauma CenterInternship, Transitional Year, 1971 - 1972
- Tulane University School of MedicineClass of 1971
Certifications & Licensure
- CA State Medical License 2011 - Present
- NY State Medical License 1977 - 2025
- TX State Medical License 1972 - 2025
- FL State Medical License 2006 - 2018
- IL State Medical License 2005 - 2017
- OH State Medical License 2005 - 2017
- SD State Medical License Active through 2017
- American Board of Radiology Diagnostic Radiology
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsBaylisascaris Procyonis Neural Larva Migrans in an Infant in New York City.Jason E. Perlman, Kevin R. Kazacos, Gavin H. Imperato, Rajen U. Desai, Susan K. Schulman
Journal of Neuroparasitology. 2010-01-01 - 21 citations0.6 T magnetic resonance imaging of the orbitJon H. Edwards, Roger A. Hyman, S. J. Vacirca, Michael A. Boxer, Samuel Packer
AJR. American Journal of Roentgenology. 1985-05-01 - 10 citationsSpinal cord infarction in meningitis: Polygenic risk factorsBenjamin P. Almasanu, Jennifer R. Owensby, Steven G. Pavlakis, Jon H. Edwards
Pediatric Neurology. 2005-02-01
Press Mentions
- Evotec and Venture Capital Consortium Form ‘Breakpoint Therapeutics Gmbh’July 8th, 2019